Intranasal and intramuscular naloxone for opioid overdose in the pre-hospital setting a review of comparative clinical and cost-effectiveness, and guidelines
The purpose of this review is to provide evidence on the comparative clinical effectiveness and cost effectiveness of the various formulations and delivery mechanisms of naloxone for the treatment of opioid poisoning. Clinical practice guidelines will also be examined
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa
Canadian Agency for Drugs and Technologies in Health
March 16, 2017, 2017
|
Edition: | Version 1.0 |
Series: | Rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The purpose of this review is to provide evidence on the comparative clinical effectiveness and cost effectiveness of the various formulations and delivery mechanisms of naloxone for the treatment of opioid poisoning. Clinical practice guidelines will also be examined |
---|---|
Physical Description: | 1 PDF file (31 pages) illustrations |